Practice variations in managing infantile hemangiomas
Thomas W. McLean1, Alexandra J.
Borst2, Adrienne M. Hammill3, Ionela
Iacobas4, Autumn Atkinson5, Tishi
Shah6, Judith F. Margolin4, Sherry
L. Bayliff7, Julie Blatt8
From the Vascular Anomalies Special Interest Group of the American
Society of Pediatric Hematology/Oncology and the Divisions of Pediatric
Hematology/Oncology
Wake Forest University School of Medicine, Winston-Salem, NC (1)
The Children’s Hospital of Philadelphia, Philadelphia, PA (2)
Cincinnati Children’s Hospital Medical Center and the University of
Cincinnati College of Medicine, Cincinnati, OH (3)
Baylor University, Texas Children’s Hospital, Houston, TX (4)
The University of Texas Health Science Center, Houston, TX (5)
Boston Children’s Hospital, Harvard Medical School, Boston, MA (6)
University of Kentucky, Lexington, KY (7)
University of North Carolina, Chapel Hill, NC (8)
Corresponding author:
Thomas W. McLean, M.D.
Department of Pediatrics
Wake Forest University School of Medicine
Medical Center Boulevard
Winston-Salem, NC 27157
Phone (336) 716-4085
Fax (336) 716-3010
email:
tmclean@wakehealth.edu
Text word count: 2018
Abstract word count: 249
Number of tables: 3
Running title: Variations in managing infantile hemangiomas
Keywords: infantile hemangiomas, propranolol, survey
Abbreviations: